Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation-Reference-Cited by-同舟云学术

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kujawski Maciej¹,Sherman Mark²,Hui Susanta³,Zuro Darren³,Lee Wen-Hui¹,Yazaki Paul¹,Sherman Anakim¹,Szpikowska Barbara¹,Chea Junie⁴,Lasiewski Desiree⁴,Poku Kofi⁴,Li Harry¹,Colcher David¹,Wong Jeffrey³,Shively John E.¹^ORCID

Affiliation:

1. Department of Molecular Imaging and Therapy, City of Hope, Duarte, CA, USA

2. School of Pharmacy, West Coast University, Los Angeles, CA, USA

3. Department of Radiation Oncology, City of Hope, Duarte, CA, USA

4. Radiopharmacy, City of Hope, Duarte, CA, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1724052

Reference49 articles.

1. Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

2. Immunocytokines: a review of molecules in clinical development for cancer therapy

3. IL-2: The First Effective Immunotherapy for Human Cancer

4. The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

5. An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy;OncoTargets and Therapy;2024-08

2. Advancements and challenges in immunocytokines: A new arsenal against cancer;Acta Pharmaceutica Sinica B;2024-08

3. Comparison of IL‐2‐antibody to IL‐2‐Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumors;Cancer Medicine;2024-02

4. Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity;Molecular Cancer Therapeutics;2023-12-21

5. Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts;Cancers;2023-08-24